Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE)
Bonn, Nordrhein-Westfalen, Germany
About Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE)
DZNE is a research institute for neurodegenerative diseases such as Alzheimer’s, Parkinson’s and ALS, which are associated with dementia, movement disorders and other serious health impairments. To date, there are no cures for these diseases, which represent an enormous burden for countless affected individuals, their families, and the healthcare system. The aim of DZNE is to develop novel strategies for prevention, diagnosis, care, as well as treatment, and to transfer them into practice. DZNE comprises ten sites across Germany, it cooperates with universities, university hospitals, research centers and other institutions in Germany and abroad. DZNE is government-funded, it is a member of the Helmholtz Association and of the German Centers for Health Research.
Company Facts
- Operating status: Active
- Company type: Non-Profit
- IPO status: Private
- Employees: 1,001 – 5,000
- Last round: Grant (Jul 2022)
- Website: dzne.de
- Phone: 49 228 433020
Industries & Categories
Life Science
Social Profiles
Canonical: https://fsome.com/organization/deutsches-zentrum-f-r-neurodegenerative-erkrankungen-dzne-2585844 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.